Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: $0
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 1 filing we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 25 most recent Form 4 transactions.
| Apellis Pharmaceuticals,… |
| DTOISS◆ |
| 45,000 |
| — |
| — |
| — |
| Open the original filing on SEC.gov |
| May 14 | APLS | Apellis Pharmaceuticals,… | DTOISS◆ | 70,125 | — | — | — | Open the original filing on SEC.gov |
| May 14 | APLS | Apellis Pharmaceuticals,… | DTOISS◆ | 60,242 | — | — | — | Open the original filing on SEC.gov |
| May 14 | APLS | Apellis Pharmaceuticals,… | DTOISS◆ | 82,500 | — | — | — | Open the original filing on SEC.gov |
| May 14 | APLS | Apellis Pharmaceuticals,… | DTOISS◆ | 23,958 | — | — | — | Open the original filing on SEC.gov |
| May 14 | APLS | Apellis Pharmaceuticals,… | DTOISS◆ | 84,946 | — | — | — | Open the original filing on SEC.gov |
| May 14 | APLS | Apellis Pharmaceuticals,… | DTOISS◆ | 232,903 | — | — | — | Open the original filing on SEC.gov |
| May 14 | APLS | Apellis Pharmaceuticals,… | DTOISS | 58,140 | — | — | -100.0% | Open the original filing on SEC.gov |
| May 14 | APLS | Apellis Pharmaceuticals,… | DTOISS | 34,447 | — | — | -100.0% | Open the original filing on SEC.gov |
| May 14 | APLS | Apellis Pharmaceuticals,… | DTOISS | 11,874 | — | — | -100.0% | Open the original filing on SEC.gov |
| May 14 | APLS | Apellis Pharmaceuticals,… | DTOISS | 6,872 | — | — | -100.0% | Open the original filing on SEC.gov |
| May 14 | APLS | Apellis Pharmaceuticals,… | DTOISS | 58,140 | — | — | -100.0% | Open the original filing on SEC.gov |
| May 14 | APLS | Apellis Pharmaceuticals,… | AGRANT | 58,140 | — | — | — | Open the original filing on SEC.gov |
| May 14 | APLS | Apellis Pharmaceuticals,… | DTOISS | 29,070 | — | — | -100.0% | Open the original filing on SEC.gov |
| May 14 | APLS | Apellis Pharmaceuticals,… | AGRANT | 29,070 | — | — | — | Open the original filing on SEC.gov |
| May 14 | APLS | Apellis Pharmaceuticals,… | DTOISS | 30,620 | — | — | -100.0% | Open the original filing on SEC.gov |
| May 14 | APLS | Apellis Pharmaceuticals,… | AGRANT | 30,620 | — | — | — | Open the original filing on SEC.gov |
| May 14 | APLS | Apellis Pharmaceuticals,… | DTOISS | 41,250 | — | — | -100.0% | Open the original filing on SEC.gov |
| May 14 | APLS | Apellis Pharmaceuticals,… | AGRANT | 41,250 | — | — | — | Open the original filing on SEC.gov |
| May 14 | APLS | Apellis Pharmaceuticals,… | UTENDR | 71,492 | — | — | -100.0% | Open the original filing on SEC.gov |
| May 14 | APLS | Apellis Pharmaceuticals,… | UTENDR | 140,945 | — | — | -100.0% | Open the original filing on SEC.gov |
| Apr 17 | APLS | Apellis Pharmaceuticals,… | GGIFT | 11,096 | — | — | +18.4% | Open the original filing on SEC.gov |
| Apr 17 | APLS | Apellis Pharmaceuticals,… | GGIFT | 11,096 | — | — | -7.3% | Open the original filing on SEC.gov |